Investigational Site Number : 2500003

Bordeaux 33076

1 studies enrolling now · 4 studies all time

What they study most

Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Hidradenitis Suppurativa, Non-squamous Non-small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck

Studies at this site

• Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa — Recruiting now
• Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Completed
• A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204) — Stopped early
• Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEA — Stopped early